Entera Bio (ENTX) Stock Chart & Stock Price History → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free ENTX Stock Alerts $1.67 +0.13 (+8.44%) (As of 03/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial Media Entera Bio Stock Price Performance5 Day Performance+5.70%1 Month Performance+21.45%3 Month Performance+178.33%6 Month Performance+130.34%Year-To-Date Performance+178.33%1 Year Performance+23.70% Receive ENTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> ENTX Stock Chart for Friday, March, 29, 2024 ENTX Chart by TradingView Entera Bio Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2024$1.54$1.67+8.44%$1.75$1.54124,619 shs$48.10 million03/27/2024$1.55$1.54-0.65%$1.64$1.4841,633 shs$44.35 million03/26/2024$1.56$1.55-0.64%$1.75$1.47211,273 shs$44.65 million03/25/2024$1.58$1.56-1.27%$1.63$1.5438,567 shs$44.93 million03/22/2024$1.72$1.58-8.14%$1.74$1.31398,422 shs$45.50 million03/21/2024$1.52$1.72+13.16%$1.76$1.46271,380 shs$49.54 million Get the Latest News and Ratings for ENTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter. 03/20/2024$1.41$1.52+7.79%$1.54$1.301.44 million shs$43.78 million03/19/2024$1.37$1.41+2.93%$1.44$1.3635,685 shs$40.61 million03/18/2024$1.37$1.37$1.44$1.3722,845 shs$39.46 million03/15/2024$1.37$1.37$1.40$1.3324,124 shs$39.46 million03/14/2024$1.45$1.37-5.52%$1.46$1.3394,839 shs$39.46 million03/13/2024$1.44$1.45+0.69%$1.50$1.4340,503 shs$41.76 million03/12/2024$1.46$1.44-1.37%$1.50$1.4392,841 shs$41.47 million03/11/2024$1.39$1.46+5.04%$1.53$1.4257,883 shs$42.05 million03/08/2024$1.46$1.39-4.79%$1.52$1.3940,458 shs$40.03 million03/07/2024$1.37$1.46+6.57%$1.50$1.3445,209 shs$42.05 million03/06/2024$1.57$1.37-12.74%$1.52$1.30299,015 shs$39.46 million03/05/2024$1.72$1.57-8.72%$1.87$1.47307,214 shs$45.22 million03/04/2024$1.44$1.72+19.44%$1.75$1.44262,879 shs$49.54 million03/01/2024$1.38$1.43+4.00%$1.44$1.25127,488 shs$41.18 million02/29/2024$1.25$1.38+10.00%$1.46$1.25207,996 shs$39.60 million02/28/2024$1.03$1.25+21.95%$1.46$1.01643,056 shs$36 million02/27/2024$1.05$1.03-2.38%$1.05$1.0078,663 shs$29.52 million02/26/2024$1.05$1.05$1.06$1.0336,380 shs$30.24 million02/23/2024$1.04$1.05+0.96%$1.08$1.0353,605 shs$30.24 million02/22/2024$1.05$1.04-0.95%$1.10$0.9552,000 shs$29.96 million02/21/2024$1.07$1.05-1.87%$1.13$1.0527,379 shs$30.24 million02/20/2024$1.06$1.07+1.42%$1.13$1.0398,339 shs$30.82 million02/19/2024$1.06$1.06$1.07$1.00117,100 shs$30.38 million02/16/2024$1.05$1.06+0.48%$1.07$1.00117,146 shs$30.38 million02/15/2024$0.85$1.05+23.69%$1.06$0.84208,299 shs$30.24 million02/14/2024$0.91$0.85-6.71%$0.90$0.8220,757 shs$24.45 million02/13/2024$0.96$0.91-5.69%$0.97$0.9115,887 shs$26.21 million02/12/2024$0.90$0.96+7.21%$0.98$0.9054,535 shs$27.79 million02/09/2024$0.84$0.90+7.21%$0.93$0.8150,056 shs$25.92 million02/08/2024$0.75$0.84+12.08%$0.84$0.71137,208 shs$24.18 million02/07/2024$0.74$0.75+1.15%$0.75$0.7418,246 shs$21.33 million02/06/2024$0.75$0.74-1.27%$0.75$0.6849,679 shs$21.33 million02/05/2024$0.84$0.75-10.61%$0.80$0.7156,162 shs$21.60 million02/02/2024$0.76$0.84+10.39%$0.84$0.7611,441 shs$24.16 million[BUY ALERT] Our #1 A.I. Stock for March (Ad)It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>>02/01/2024$0.83$0.76-8.41%$0.84$0.7634,759 shs$21.89 million01/31/2024$0.87$0.83-4.62%$0.86$0.8045,079 shs$23.90 million01/30/2024$0.89$0.87-1.96%$0.88$0.8518,961 shs$25.06 million01/29/2024$0.87$0.89+1.93%$0.95$0.8434,086 shs$25.56 million01/26/2024$0.86$0.86+1.04%$0.93$0.8328,937 shs$24.91 million01/25/2024$0.86$0.86-0.48%$0.92$0.8430,195 shs$24.65 million01/24/2024$0.88$0.86-2.24%$0.87$0.8340,349 shs$24.77 million01/23/2024$0.94$0.88-6.70%$0.96$0.8655,294 shs$25.34 million01/22/2024$1.00$0.94-5.70%$1.01$0.8591,689 shs$27.16 million01/19/2024$1.03$0.98-5.33%$1.04$0.94111,009 shs$28.08 million01/18/2024$1.06$1.03-2.83%$1.12$1.0176,502 shs$29.66 million01/17/2024$1.10$1.06-3.64%$1.14$0.98153,285 shs$30.53 million01/16/2024$1.09$1.10+0.92%$1.31$1.07616,121 shs$31.68 million01/15/2024$1.09$1.09$1.09$0.80484,800 shs$31.39 million01/12/2024$0.81$1.08+32.84%$1.09$0.80482,438 shs$31.10 million01/11/2024$0.80$0.81+1.61%$0.83$0.8029,073 shs$23.41 million01/10/2024$0.76$0.80+5.28%$0.81$0.7598,279 shs$23.04 million01/09/2024$0.75$0.76+0.68%$0.78$0.7272,859 shs$21.89 million01/08/2024$0.68$0.75+11.61%$0.76$0.66140,160 shs$21.74 million01/05/2024$0.69$0.68-1.04%$0.69$0.6535,321 shs$19.52 million01/04/2024$0.65$0.69+6.20%$0.69$0.6451,351 shs$19.73 million01/03/2024$0.64$0.65+0.78%$0.66$0.5868,197 shs$18.58 million01/02/2024$0.60$0.64+6.67%$0.66$0.61163,644 shs$18.43 million01/01/2024$0.60$0.60$0.64$0.52401,100 shs$17.28 million12/29/2023$0.55$0.60+8.95%$0.64$0.52399,577 shs$17.28 million12/28/2023$0.63$0.55-12.59%$0.65$0.55389,409 shs$15.86 million Related Companies: CASI Pharmaceuticals Stock Chart Estrella Immunopharma Stock Chart Gamida Cell Stock Chart Pluri Stock Chart OKYO Pharma Stock Chart IN8bio Stock Chart Candel Therapeutics Stock Chart Cortexyme Stock Chart Protara Therapeutics Stock Chart Cyclo Therapeutics Stock Chart Receive ENTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENTX) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the MarketsBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.